Healthcare

Dorsavi Ltd (ASX:DVL)

Industry Group : Health Care Equipment & Services | Industry Group Name : Health Care Equipment & Supplies

Market Price : AUD 0.0210 (0%)

(as on 2021-11-30 20:55:50 AEDT)

Market Cap : AUD 7.38 M

Previous Close Open Close* Day Range 52 WEEK HIGH LOW
0.021 0.021 0.021 0.020L 0.021 H 0.018L 0.080 H
Last Trade 0.021
Change% 0.0000
52 W H/L 0.080/0.018
EBITDA -1.962 M
NPAT After Abnormal Items -2.028 M
Equity 2.163 M
ROE% -93.76%
Total Liabilities 2.899 M
Total Revenue 2.769 M
Cash and Cash Equivalents 2.796 M

Stock Information

Share price 0.021
Market Cap 7.38 M
Price/Gross Cash Flow -7.19
Dividend Yield Excluding Special 0.00%
Ending Shares 350.933 M
52-Week Range 0.080-0.018
P/E ratio 0.000
Sector P/E --
EPS -0.68
EV/EBITDA --
Net Profit Margin (%) -108.52%
Gross Cash Flows Per Share -0.00
Net Gearing -50.80%
Gross DPS (AUD) 0
Gross Dividend Yield (Annualized) 0.00%
Earnings Yield 0.000
Net Tangible Asset (NTA) 0.01
Sales Per Share 0.01
Book Value Per Share 0.01

Announcements

Heading Date/Time
Jobkeeper Payments Notice  08/11/2021 8:25AM
Quarterly Activities/Appendix 4C Cash Flow Report  27/10/2021 8:44AM
Notice of Annual General Meeting/Proxy Form  25/10/2021 9:21AM
Appendix 3Y  11/10/2021 9:48AM
Appendix 3Y  11/10/2021 9:47AM
Appendix 3Y  11/10/2021 9:46AM
Appendix 3Y  11/10/2021 9:45AM
Notification regarding unquoted securities - DVL  11/10/2021 9:44AM
Annual General Meeting  06/10/2021 9:43AM
dorsaVi appoints Troy Di Domenico as CFO  04/10/2021 9:26AM
Notification of Intention to Retire as Chairman  22/09/2021 8:55AM
Appendix 3Y  09/09/2021 9:32AM
Cleansing Notice  30/08/2021 9:26AM
Application for quotation of securities - DVL  30/08/2021 9:23AM
Corporate Governance Statement and Appendix 4G  26/08/2021 1:49PM
DVL 2021 Results Announcement  26/08/2021 1:29PM
Appendix 4E and Annual Report  26/08/2021 1:23PM
dorsaVi extends agreement with Medtronic  05/08/2021 9:46AM
Appendix 4C and Quarterly Activities Report  30/07/2021 9:06AM
Notification regarding unquoted securities - DVL  06/07/2021 1:57PM
Appendix 3Y  06/07/2021 10:00AM
Appendix 3Y  06/07/2021 10:00AM
Appendix 3Y  06/07/2021 9:59AM
Appendix 3Y  06/07/2021 9:58AM
CEO Investor Presentation  06/05/2021 11:49AM
Appendix 4C and Quarterly Activities Report  27/04/2021 9:37AM
Appendix 3Y  14/04/2021 11:12AM
Appendix 3Y  14/04/2021 11:11AM
Appendix 3Y  14/04/2021 11:10AM

Similar Companies

Related Articles

About Company

The company is under health care sector and is supplying medical, sporting and occupational health and safety products devices and services, with medical research and development. The company was listed in 2013 under the Pharmaceuticals, Biotechnology & Life Sciences segment, and the headquarter is situated in William Street, Melbourne, Australia.

Corporate Information

company address c/- Pitcher Partners, Level 13, 664 Collins Street,, DOCKLANDS, VIC, AUSTRALIA, 3008

company phone1800 367 728

company websitehttp://www.dorsavi.com

Dividends

Year-end Date Franking DPS (AUD) Dividend Yield
30/06/2021 -- 0.000 0.00%
30/06/2020 -- 0.000 0.00%
30/06/2019 -- 0.000 0.00%
30/06/2018 -- 0.000 0.00%
30/06/2017 -- 0.000 0.00%
30/06/2016 -- 0.000 0.00%
30/06/2015 -- 0.000 0.00%
30/06/2014 -- 0.000 0.00%
30/06/2013 -- 0.000 --

Event Calendar

Event Type Event Date Event Year
Report (Annual) 2022-08-25 2022
Report (Prelim) 2022-08-25 2022
Report (Interim) 2022-02-22 2022
AGM 2021-11-26 2021

Financials

Breakdown 30/06/2021 30/06/2020 30/06/2019 30/06/2018 30/06/2017
Trading Revenue 1.869 M 2.019 M 2.515 M 3.433 M 3.466 M
Other Revenue 899,526 278,252 662,267 848,741 283,267
Total Revenue 2.769 M 2.297 M 3.177 M 4.282 M 3.749 M
Interest Income 11,125 99,587 46,610 112,182 148,588
Interest Expenses -274,154 -167,451 -32,136 0 0
Expenses -4.741 M -9.24 M -6.813 M -8.185 M -8.441 M
EBITDA -1.973 M -6.943 M -3.636 M -3.903 M -4.691 M
Depreciation and Amortization -210,203 -1.04 M -965,854 -738,281 -174,677
Depreciation -176,619 -203,357 -182,377 -117,342 -91,916
Amortisation -33,584 -836,290 -783,477 -620,939 -82,761
EBIT -2.183 M -7.983 M -4.602 M -4.641 M -4.866 M
Pre Tax Profit -2.446 M -8.05 M -4.587 M -4.529 M -4.717 M
Tax Expense 417,830 457,364 566,649 913,671 841,199
Net Profit After Tax -2.028 M -7.593 M -4.021 M -3.615 M -3.876 M
Minority Interest 0 0 0 0 0
Preference Dividend 0 0 0 0 0
Net Abnormal Items 0 0 0 -112,110 0
Reported Net Profit After Abnormal Items -2.028 M -7.593 M -4.021 M -3.727 M -3.876 M
Ending Shares 350.933 M 242.054 M 213.385 M 182.341 M 181.676 M
Weighted Average Shares 296.434 M 227.378 M 195.508 M 182.185 M 172.111 M
EPS After Abnormal Items (cents) -0.68 -3.34 -2.06 -2.05 -2.25
Breakdown 30/06/2021 30/06/2020 30/06/2019 30/06/2018 30/06/2017
Total Current Assets 4.808 M 3.449 M 4.581 M 6.717 M 11.483 M
Total Non Current Assets 253,621 378,411 4.648 M 4.209 M 2.988 M
Total Assets 5.062 M 3.828 M 9.229 M 10.925 M 14.472 M
Total Current Liabilities 1.547 M 1.774 M 1.979 M 1.466 M 1.316 M
Total Non Current Liabilities 1.352 M 1.595 M 260,576 41,858 30,340
Total Liabilities 2.899 M 3.369 M 2.239 M 1.508 M 1.346 M
Net Assets 2.163 M 459,029 6.989 M 9.417 M 13.126 M
Breakdown 30/06/2021 30/06/2020 30/06/2019 30/06/2018 30/06/2017
Net Operating Cash -2.27 M -2.18 M -2.083 M -2.597 M -3.387 M
Net Invested Cash -85,413 -788,802 -1.003 M -2.06 M -1.764 M
Net Financing Cash Flows 3.467 M 1.887 M 1.886 M 14,706 7.731 M
Beginning Cash 1.685 M 2.766 M 3.967 M 8.61 M 6.029 M
End Cash Position 2.796 M 1.685 M 2.766 M 3.967 M 8.61 M
Exchange Rate Adjustments 0 0 0 0 0
Other Cash Adjustments 0 0 0 0 0
Ending Cash 2.796 M 1.685 M 2.766 M 3.967 M 8.61 M

© Morningstar, Inc. 2021. All rights reserved. Neither Morningstar, its affiliates, nor the content providers guarantee the market indices, commodities and regulatory news headlines, and other data or content contained herein to be accurate, complete, or timely, and nor shall they have any liability for its use or distribution. The data contained herein: (1) is proprietary to Morningstar and/or its affiliates (collectively, “Morningstar”) and/or their content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete, or timely. Our publications, ratings and products should be viewed as an additional investment resource, and not as your sole source of information. Past performance does not necessarily indicate a financial product’s future performance. To obtain advice tailored to your financial situation, contact a professional financial adviser. Some material is copyrighted and published under licence from ASX Operations Pty. Ltd. ACN 004523782.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK